This invention relates to crystal form II of 2-[2-(1-chlorocyclopropyl)-3-(2-chloropenyl)-2-hydroxypropyl]-2,4-dihydro- -3H-1,2,4-triazole-3-thione of the formula ##STR00001## to a process for its preparation and to its use for controlling unwanted microorganisms.